Quintiles Wins Society for Clinical Research Sites’ 2015 Eagle Award

Recognized for leadership in site support for third consecutive year

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Quintiles today announced that it has been awarded the Society for
Clinical Research Sites’ (SCRS) 2015 Clinical Research Organization
(CRO) Eagle Award. Presented during the annual SCRS Site Solutions
Summit, the award honors outstanding leadership, professionalism,
integrity, passion and dedication when working with sites.

“It is a tremendous honor to be recognized for this award three years in
a row,” said Jeanne Hecht, senior vice president and global head, Site &
Patient Networks at Quintiles. “This award reflects Quintiles’
commitment to continually enhancing site relationships. I would like to
thank our dedicated employees at Quintiles, as well as the talented
individuals and teams with whom we work at investigator sites around the
world. Together we have a relentless focus to accelerate the delivery of
needed therapies to patients.”

“We are pleased to present the Eagle Award to Quintiles,” said SCRS
President Christine Pierre. “The award reflects the opinions of
investigative sites across the globe and is a true illustration of
Quintiles’ dedication to partnering successfully with sites.”

Prior to the Site Solutions Summit, SCRS members, which are
investigative sites, were invited to nominate the sponsor and CRO they
believe best demonstrates partnership commitment. Additional award
criteria also included: availability of qualified staff to support the
sites, demonstration of collaboration, protocol design and execution,
financial consideration, and partnering with sites for future work.

For more information about the SCRS Eagle Award, visit http://sitesolutionssummit.com/eagle-awards/.

About Quintiles

Quintiles (NYSE: Q) helps biopharma and other healthcare companies
improve their probability of success by connecting insights from our
deep scientific, therapeutic and analytics expertise with superior
delivery for better outcomes. From advisory through operations,
Quintiles is the world’s largest provider of product development and
integrated healthcare services, including commercial and observational
solutions. Conducting operations in approximately 100 countries,
Quintiles is a member of the FORTUNE 500 and has been named to FORTUNE’s
list of the “World’s Most Admired Companies.” To learn more, visit www.quintiles.com.

Click here
to subscribe to Mobile Alerts for Quintiles.

Contacts

Quintiles
Media Relations:
Phil Bridges, +1-919-998-1653
Mobile:
+1-919-457-6347
phil.bridges@quintiles.com
or
Investor
Relations:
Todd Kasper, +1-919-998-2590
InvestorRelations@quintiles.com